New kidney drug AZD4248 enters first human safety trials

NCT ID NCT07024823

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 20 times

Summary

This early-stage study tests the safety of a new drug called AZD4248 in healthy volunteers and people with chronic kidney disease and type 2 diabetes. Researchers will give single or multiple doses of the drug and watch for side effects. The study also checks if people can reliably measure their kidney function at home using a simple test. About 124 participants will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Glendale, California, 91206, United States

  • Research Site

    RECRUITING

    Chicago, Illinois, 60643, United States

  • Research Site

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Research Site

    RECRUITING

    Saint Paul, Minnesota, 55114, United States

  • Research Site

    RECRUITING

    San Antonio, Texas, 78215, United States

Conditions

Explore the condition pages connected to this study.